Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04999969
Title Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

pancreatic adenocarcinoma

Therapies

AZD0171 + Durvalumab + Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN


No variant requirements are available.